← Back to Search

Acetaminophen and Diphenhydramine Only Product for Thrombocytopenic Purpura

Phase 1

Waitlist Available

Research Sponsored by Baylor College of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will test if it's possible to enroll children with ITP who are receiving IVIG for treatment, and if they're willing to participate in a scheduled medication regimen. They will also test if patients and families are able to stick to the schedule.

Eligible Conditions

Idiopathic Thrombocytopenic Purpura (ITP)

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of Eligible Patients Agreeing to Enrollment

Secondary outcome measures

Percentage of Enrolled Patients who Achieve Medication Adherence

Rate of Laboratory Evaluation with Platelet Count During Emergent Medical Evaluation

Cognitive Therapy

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Scheduled post-IVIG medicationExperimental Treatment1 Intervention

Utilization of post-IVIG medication with acetaminophen and diphenhydramine on a scheduled basis of 72 hours post-infusion.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor

1,001 Previous Clinical Trials

6,001,932 Total Patients Enrolled

Media Library

Acetaminophen and Diphenhydramine Only Product Clinical Trial Eligibility Overview. Trial Name: NCT04741139 — Phase 1

Thrombocytopenic Purpura Research Study Groups: Scheduled post-IVIG medication

Thrombocytopenic Purpura Clinical Trial 2023: Acetaminophen and Diphenhydramine Only Product Highlights & Side Effects. Trial Name: NCT04741139 — Phase 1

Acetaminophen and Diphenhydramine Only Product 2023 Treatment Timeline for Medical Study. Trial Name: NCT04741139 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are senior citizens eligible to take part in this clinical trial?

"According to the medical trial's requirements, patients wishing to be enrolled must have a minimum age of 1 Month and maximum age of 18."

Answered by AI

For what maladies is Acetaminophen and Diphenhydramine Only Product commonly prescribed?

"Acetaminophen and Diphenhydramine Only Product is a prescribed medication utilized to relieve pain, catarrh, and rhinorrhoea."

Answered by AI

Are applications for this investigation still being received?

"As of now, the clinical trial hosted on clinicialtrials.gov is recruiting patients and has been since October 20th 2021. The latest update to the study came in April 11th 2022."

Answered by AI

Has the Acetaminophen and Diphenhydramine combination been certified by the FDA?

"The safety of Acetaminophen and Diphenhydramine Only Product is assessed at a 1 as this is an early stage clinical trial. There are minimal data points indicating its efficacy or risk profile."

Answered by AI

What is the total number of research subjects involved in this experiment?

"Affirmative. The clinicaltrial.gov portal has documented that this trial, which was initially listed on October 20th 2021, is actively enrolling patients. Approximately 20 people are needed from one medical facility to participate in the study."

Answered by AI

Who is eligible to participate in this experimental venture?

"Presently, this trial is accepting 20 sufferers of thrombocytopenia aged 1 Month to 18. All participants must have a confirmed diagnosis from the haematology team and be undergoing IVIG treatment as prescribed by their primary care provider, regardless if it was given in an outpatient or emergency setting."

Answered by AI

What prior research has been undertaken on the effects of Acetaminophen and Diphenhydramine Only Product?

"At present, there are 104 studies concerning the combination of Acetaminophen and Diphenhydramine Only Product. Of these trials, 30 have moved into Phase 3. In addition to Taichung, Florida, over a thousand sites around the world are currently running research for this particular product."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Post IVIG Medication in Children With Immune Thrombocytopenia

Megan Gilbert 2021. "Post IVIG Medication in Children With Immune Thrombocytopenia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04741139.

All > Thrombocytopenia